Literature DB >> 32934035

Research in brief: Serum urate reduction and its effect on the progression of chronic kidney disease.

Rajan S Pooni1, Richard Corbett2.   

Abstract

Entities:  

Year:  2020        PMID: 32934035      PMCID: PMC7539703          DOI: 10.7861/clinmed.rib.20.5.1

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  11 in total

1.  Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.

Authors:  Yui-Pong Siu; Kay-Tai Leung; Matthew Ka-Hang Tong; Tze-Hoi Kwan
Journal:  Am J Kidney Dis       Date:  2006-01       Impact factor: 8.860

2.  The burden of chronic kidney disease.

Authors:  Rizwan A Hamer; A Meguid El Nahas
Journal:  BMJ       Date:  2006-03-11

3.  Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes.

Authors:  Sascha Pilemann-Lyberg; Tine Willum Hansen; Nete Tofte; Signe Abitz Winther; Simone Theilade; Tarunveer Singh Ahluwalia; Peter Rossing
Journal:  Diabetes Care       Date:  2019-03-18       Impact factor: 19.112

Review 4.  Uric acid as a target of therapy in CKD.

Authors:  Diana I Jalal; Michel Chonchol; Wei Chen; Giovanni Targher
Journal:  Am J Kidney Dis       Date:  2012-10-09       Impact factor: 8.860

5.  Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data.

Authors:  Maryam Afkarian; Sarit Polsky; Afshin Parsa; Ronnie Aronson; Maria Luiza Caramori; David Z Cherney; Jill P Crandall; Ian H de Boer; Thomas G Elliott; Andrzej T Galecki; Allison B Goldfine; J Sonya Haw; Irl B Hirsch; Amy B Karger; Ildiko Lingvay; David M Maahs; Janet B McGill; Mark E Molitch; Bruce A Perkins; Rodica Pop-Busui; Marlon Pragnell; Sylvia E Rosas; Peter Rossing; Peter Senior; Ronald J Sigal; Catherine Spino; Katherine R Tuttle; Guillermo E Umpierrez; Amisha Wallia; Ruth S Weinstock; Chunyi Wu; Michael Mauer; Alessandro Doria
Journal:  Diabetes Care       Date:  2019-06-11       Impact factor: 19.112

6.  Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.

Authors:  Kenjiro Kimura; Tatsuo Hosoya; Shunya Uchida; Masaaki Inaba; Hirofumi Makino; Shoichi Maruyama; Sadayoshi Ito; Tetsuya Yamamoto; Yasuhiko Tomino; Iwao Ohno; Yugo Shibagaki; Satoshi Iimuro; Naohiko Imai; Masanari Kuwabara; Hiroshi Hayakawa; Hiroshi Ohtsu; Yasuo Ohashi
Journal:  Am J Kidney Dis       Date:  2018-09-01       Impact factor: 8.860

7.  Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.

Authors:  Marian Goicoechea; Soledad Garcia de Vinuesa; Ursula Verdalles; Eduardo Verde; Nicolas Macias; Alba Santos; Ana Pérez de Jose; Santiago Cedeño; Tania Linares; Jose Luño
Journal:  Am J Kidney Dis       Date:  2015-01-13       Impact factor: 8.860

Review 8.  Uric Acid and Diabetic Nephropathy Risk.

Authors:  Michael Mauer; Alessandro Doria
Journal:  Contrib Nephrol       Date:  2018-01-23       Impact factor: 1.580

9.  Uric acid and incident kidney disease in the community.

Authors:  Daniel E Weiner; Hocine Tighiouart; Essam F Elsayed; John L Griffith; Deeb N Salem; Andrew S Levey
Journal:  J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 10.121

10.  Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels.

Authors:  Adrienne Tin; Jonathan Marten; Victoria L Halperin Kuhns; Yong Li; Matthias Wuttke; Holger Kirsten; Karsten B Sieber; Chengxiang Qiu; Mathias Gorski; Zhi Yu; Ayush Giri; Gardar Sveinbjornsson; Man Li; Audrey Y Chu; Anselm Hoppmann; Luke J O'Connor; Bram Prins; Teresa Nutile; Damia Noce; Masato Akiyama; Massimiliano Cocca; Sahar Ghasemi; Peter J van der Most; Katrin Horn; Yizhe Xu; Christian Fuchsberger; Sanaz Sedaghat; Saima Afaq; Najaf Amin; Johan Ärnlöv; Stephan J L Bakker; Nisha Bansal; Daniela Baptista; Sven Bergmann; Mary L Biggs; Ginevra Biino; Eric Boerwinkle; Erwin P Bottinger; Thibaud S Boutin; Marco Brumat; Ralph Burkhardt; Eric Campana; Archie Campbell; Harry Campbell; Robert J Carroll; Eulalia Catamo; John C Chambers; Marina Ciullo; Maria Pina Concas; Josef Coresh; Tanguy Corre; Daniele Cusi; Sala Cinzia Felicita; Martin H de Borst; Alessandro De Grandi; Renée de Mutsert; Aiko P J de Vries; Graciela Delgado; Ayşe Demirkan; Olivier Devuyst; Katalin Dittrich; Kai-Uwe Eckardt; Georg Ehret; Karlhans Endlich; Michele K Evans; Ron T Gansevoort; Paolo Gasparini; Vilmantas Giedraitis; Christian Gieger; Giorgia Girotto; Martin Gögele; Scott D Gordon; Daniel F Gudbjartsson; Vilmundur Gudnason; Toomas Haller; Pavel Hamet; Tamara B Harris; Caroline Hayward; Andrew A Hicks; Edith Hofer; Hilma Holm; Wei Huang; Nina Hutri-Kähönen; Shih-Jen Hwang; M Arfan Ikram; Raychel M Lewis; Erik Ingelsson; Johanna Jakobsdottir; Ingileif Jonsdottir; Helgi Jonsson; Peter K Joshi; Navya Shilpa Josyula; Bettina Jung; Mika Kähönen; Yoichiro Kamatani; Masahiro Kanai; Shona M Kerr; Wieland Kiess; Marcus E Kleber; Wolfgang Koenig; Jaspal S Kooner; Antje Körner; Peter Kovacs; Bernhard K Krämer; Florian Kronenberg; Michiaki Kubo; Brigitte Kühnel; Martina La Bianca; Leslie A Lange; Benjamin Lehne; Terho Lehtimäki; Jun Liu; Markus Loeffler; Ruth J F Loos; Leo-Pekka Lyytikäinen; Reedik Magi; Anubha Mahajan; Nicholas G Martin; Winfried März; Deborah Mascalzoni; Koichi Matsuda; Christa Meisinger; Thomas Meitinger; Andres Metspalu; Yuri Milaneschi; Christopher J O'Donnell; Otis D Wilson; J Michael Gaziano; Pashupati P Mishra; Karen L Mohlke; Nina Mononen; Grant W Montgomery; Dennis O Mook-Kanamori; Martina Müller-Nurasyid; Girish N Nadkarni; Mike A Nalls; Matthias Nauck; Kjell Nikus; Boting Ning; Ilja M Nolte; Raymond Noordam; Jeffrey R O'Connell; Isleifur Olafsson; Sandosh Padmanabhan; Brenda W J H Penninx; Thomas Perls; Annette Peters; Mario Pirastu; Nicola Pirastu; Giorgio Pistis; Ozren Polasek; Belen Ponte; David J Porteous; Tanja Poulain; Michael H Preuss; Ton J Rabelink; Laura M Raffield; Olli T Raitakari; Rainer Rettig; Myriam Rheinberger; Kenneth M Rice; Federica Rizzi; Antonietta Robino; Igor Rudan; Alena Krajcoviechova; Renata Cifkova; Rico Rueedi; Daniela Ruggiero; Kathleen A Ryan; Yasaman Saba; Erika Salvi; Helena Schmidt; Reinhold Schmidt; Christian M Shaffer; Albert V Smith; Blair H Smith; Cassandra N Spracklen; Konstantin Strauch; Michael Stumvoll; Patrick Sulem; Salman M Tajuddin; Andrej Teren; Joachim Thiery; Chris H L Thio; Unnur Thorsteinsdottir; Daniela Toniolo; Anke Tönjes; Johanne Tremblay; André G Uitterlinden; Simona Vaccargiu; Pim van der Harst; Cornelia M van Duijn; Niek Verweij; Uwe Völker; Peter Vollenweider; Gerard Waeber; Melanie Waldenberger; John B Whitfield; Sarah H Wild; James F Wilson; Qiong Yang; Weihua Zhang; Alan B Zonderman; Murielle Bochud; James G Wilson; Sarah A Pendergrass; Kevin Ho; Afshin Parsa; Peter P Pramstaller; Bruce M Psaty; Carsten A Böger; Harold Snieder; Adam S Butterworth; Yukinori Okada; Todd L Edwards; Kari Stefansson; Katalin Susztak; Markus Scholz; Iris M Heid; Adriana M Hung; Alexander Teumer; Cristian Pattaro; Owen M Woodward; Veronique Vitart; Anna Köttgen
Journal:  Nat Genet       Date:  2019-10-02       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.